← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:751 | 751 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:751 | 751 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:751 | 751 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-18 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:751 | 751 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-2 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:751 | 751 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5535 | 72934-5535-4 | Lidocaine; Tetracaine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:751 | 751 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:752 | 752 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-055 | 71506-055-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:752 | 752 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Esmolol Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:752 | 752 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:752 | 752 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-62 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-9 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6627 | 71300-6627-2 | Ketoprofen | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:752 | 752 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-2 | Lidocaine; Tetracaine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:752 | 752 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:752 | 752 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methohexital Sodium | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:753 | 753 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0059 | 26436-0059-2 | Tadalafil | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:753 | 753 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:753 | 753 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:753 | 753 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-30 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:753 | 753 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5417 | 72934-5417-2 | Lidocaine; Mupirocin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:753 | 753 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:753 | 753 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:754 | 754 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-3 | BLT Topical Gel | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:754 | 754 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-63 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:754 | 754 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Gabapentin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5403 | 72934-5403-4 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5537 | 72934-5537-4 | Lidocaine; Tetracaine; Benzocaine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:754 | 754 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:754 | 754 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methotrexate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:755 | 755 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | ESTRADIOL 20 PEL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:755 | 755 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-16 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-30 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9091 | 71266-9091-1 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-433 | 70092-433-50 | Ketorolac Tromethamine; Racepinephrine Hydrochloride; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:755 | 755 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:755 | 755 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:755 | 755 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:755 | 755 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6305 | 72682-6305-1 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:756 | 756 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | E2 12.5mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:756 | 756 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-322 | 70004-322-55 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:756 | 756 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:756 | 756 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-909 | 69194-909-01 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:756 | 756 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:756 | 756 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:756 | 756 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:756 | 756 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6310 | 72682-6310-1 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:757 | 757 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:757 | 757 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9001 | 26436-9001-2 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-63 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-323 | 70004-323-30 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:757 | 757 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-2 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:757 | 757 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-908 | 69194-908-01 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5402 | 72934-5402-4 | Lidocaine; Tetracaine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:757 | 757 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-161 | 73177-161-43 | Methadone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:757 | 757 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-051 | 73198-051-10 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:758 | 758 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate Monohydrate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:758 | 758 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:758 | 758 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:758 | 758 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:758 | 758 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-050 | 71170-050-05 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:758 | 758 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:758 | 758 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:758 | 758 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-051 | 73198-051-30 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:759 | 759 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-054 | 70092-054-05 | Vancomycin PF 1.25 g add to 250ml NS bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:759 | 759 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:759 | 759 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:759 | 759 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:759 | 759 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:759 | 759 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:759 | 759 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-43 | Methadone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:759 | 759 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:760 | 760 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9005 | 71266-9005-5 | Rocuronium Bromide | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Phenylephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-02 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:760 | 760 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1006 | 73271-1006-1 | Lidocaine; Tetracaine; Benzocaine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2440 | 72627-2440-1 | Methionine; Choline Chloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:760 | 760 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-006 | 67157-006-30 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:761 | 761 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3570 | 72934-3570-2 | Abenor | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:761 | 761 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1020 | 71283-1020-1 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:761 | 761 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:761 | 761 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Phenylephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:761 | 761 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-046 | 71506-046-45 | Labetalol Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-06 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:761 | 761 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5405 | 72934-5405-4 | Lidocaine; Tetracaine; Benzocaine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:761 | 761 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:761 | 761 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 85933-007 | 85933-007-30 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:762 | 762 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0124 | 70168-0124-1 | Testo200mgCHOL BLNT2 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:762 | 762 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:762 | 762 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:762 | 762 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:762 | 762 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:762 | 762 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-009 | 70092-009-44 | Labetalol Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-103 | 73463-103-06 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-9 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0415 | 71285-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:762 | 762 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:763 | 763 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8101 | 70168-8101-1 | Testosterone 25mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:763 | 763 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-22 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:763 | 763 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:763 | 763 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:763 | 763 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 |